Emergent BioSolutions Inc. (EBS) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Emergent BioSolutions Inc...

    NYSE: EBS · Real-Time Price · USD
    8.15
    -0.08 (-0.97%)
    At close: Sep 12, 2025, 3:59 PM
    8.14
    -0.12%
    After-hours: Sep 12, 2025, 07:34 PM EDT

    Emergent BioSolutions Cash Flow Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Net Income
    		 -190.6M -760.5M -223.8M 230.9M
    Depreciation & Amortization
    		 108.8M 125.1M 143.3M 123.8M
    Stock-Based Compensation
    		 18M 23.1M 45.1M 42.4M
    Other Working Capital
    		 170.6M -59.9M -48.3M -61.7M
    Other Non-Cash Items
    		 39.3M 485.2M 19.8M 33.5M
    Deferred Income Tax
    		 -5.5M -8.9M -19M 46.9M
    Change in Working Capital
    		 88.7M -70.3M 500K -156.4M
    Operating Cash Flow
    		 58.7M -206.3M -34.1M 321.1M
    Capital Expenditures
    		 -22.9M -51.6M -115.8M -225M
    Cash Acquisitions
    		 n/a 270.2M n/a n/a
    Purchase of Investments
    		 n/a n/a n/a n/a
    Sales Maturities Of Investments
    		 n/a n/a n/a n/a
    Other Investing Acitivies
    		 148.1M -6.3M -265.5M n/a
    Investing Cash Flow
    		 125.2M 212.3M -381.3M -225M
    Debt Repayment
    		 -198.4M -543.4M 564.2M -35.9M
    Common Stock Repurchased
    		 n/a n/a -82.1M -106M
    Dividend Paid
    		 n/a n/a n/a n/a
    Other Financial Acitivies
    		 -1.2M -700K -900K 900K
    Financial Cash Flow
    		 -190M -535.7M 481.2M -141M
    Net Cash Flow
    		 -6.1M -530.9M 66.3M -45.2M
    Free Cash Flow
    		 35.8M -257.9M -149.9M 96.1M

    Add to Watchlist